STRATA Skin Sciences (SSKN) Registration Filing summary

Company overview and business model

• Medical technology company focused on dermatology, developing and marketing devices for treating skin conditions such as psoriasis, vitiligo, eczema, and acne.

• Key products include XTRAC excimer lasers, VTRAC lamp systems, and TheraClearX Acne Therapy System, with FDA clearances and international approvals.

• Incorporated in 1989, with several name changes and currently headquartered in Horsham, Pennsylvania.

Financial performance and metrics

• As of November 21, 2024, 4,171,161 shares of common stock outstanding; no preferred stock issued.

• Aggregate market value of outstanding common stock held by non-affiliates is approximately $6.8 million.

• In the prior 12 months, approximately $2.1 million in common stock sold under a previous Form S-3.

Use of proceeds and capital allocation

• Net proceeds intended for clinical and regulatory advancement, commercialization, potential acquisitions, and working capital.

• Management retains broad discretion over timing and application of proceeds; funds may be temporarily invested in short-term, interest-bearing instruments.